# Retinal Oxygenation Estimation Trial With Mantis Photonics Hyperspectral Camera

> **NCT05566626** · NA · UNKNOWN · sponsor: **Mantis Photonics AB** · enrollment: 120 (estimated)

## Conditions studied

- Glaucoma Eye
- Macular Degeneration
- Macula Abnormality
- Retinal Detachment

## Interventions

- **DEVICE:** Hyperspectral retinal image
- **DRUG:** Mydriacyl Ophthalmic Product

## Key facts

- **NCT ID:** NCT05566626
- **Lead sponsor:** Mantis Photonics AB
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-10
- **Primary completion:** 2023-11
- **Final completion:** 2023-12
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2022-10-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05566626

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05566626, "Retinal Oxygenation Estimation Trial With Mantis Photonics Hyperspectral Camera". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05566626. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*